General Information of Drug (ID: DMC70P1)

Drug Name
3-hydroxy capric acid Drug Info
Synonyms 3-OH-C10; 3-hydroxy-decanoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
26612
ChEBI ID
CHEBI:132983
CAS Number
CAS 14292-26-3
TTD Drug ID
DMC70P1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PBI-4050 DMPXK27 Idiopathic pulmonary fibrosis CB03.4 Phase 2 [3]
SHR0534 DMGFTAI Type 2 diabetes 5A11 Phase 1 [4]
2-hydroxy capric acid DMJAN52 Discovery agent N.A. Investigative [2]
6-n-octylaminouracil DMXJFCQ Discovery agent N.A. Investigative [2]
3-hydroxylauric acid DMNMB6V Discovery agent N.A. Investigative [2]
2-hydroxylauric acid DMCNW3M Discovery agent N.A. Investigative [2]
undecanoic acid DMFOIPL Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Inflammation-related GPCR EX33 (GPR84) TTG0MQD GPR84_HUMAN Agonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5848).
2 Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem. 2013 Apr 12;288(15):10684-91.
3 Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2019 Mar 18;53(3):1800663.
4 Targeting metabolic dysregulation for fibrosis therapy. Nat Rev Drug Discov. 2020 Jan;19(1):57-75.
5 Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem. 2006 Nov 10;281(45):34457-64.